Faha Philip Sager, based in San Francisco, CA, US, is currently a Pharmaceutical and Device Consultant and Chair, Scientific Committee, Cardiac Safety Research Consortium at Sager Consulting Experts, bringing experience from previous roles at Thryv Therapeutics Inc., Stanford University School of Medicine, Anthera Pharmaceuticals and FDA. Faha Philip Sager holds a 1982 - 1988 Yale University School of Medicine. With a robust skill set that includes Clinical Trials, Consulting, CRO, Electrophysiology, Cardiology and more, Faha Philip Sager contributes valuable insights to the industry. Faha Philip Sager has 5 emails on RocketReach.